Výsledky vyhledávání - "David A. Catanzaro, PharmD"

Akademický článek

Increasing Eligibility to Transplant Through the Selective Cytopheretic Device: A Review of Case Reports Across Multiple Clinical Conditions

Autor: Sai Prasad N. Iyer, PhD, Christopher J. Pino, PhD, Lenar T. Yessayan, MD, Stuart L. Goldstein, MD, Matthew R. Weir, MD, Angela J. Westover, BS, David A. Catanzaro, PharmD, Kevin K. Chung, MD, H. David Humes, MD

Publikováno v: Transplantation Direct, Vol 10, Iss 6, p e1627 (2024)

A stable, minimum physiological health status is required for patients to qualify for transplant or artificial organ support eligibility to ensure the recipient has enough reserve to survive the perioperative transplant period. Herein, we present a n

Externí odkaz: https://doaj.org/article/26274fe23cf24edd81834180c8fbe26f

Zobrazit plný text záznamu

Akademický článek

Safety Summary of the Selective Cytopheretic Device: A Review of Safety Data Across Multiple Clinical Trials in ICU Patients With Acute Kidney Injury and Multiple Organ Failure

Autor: H. David Humes, MD, Stuart L. Goldstein, MD, Lenar T. Yessayan, MD, David A. Catanzaro, PharmD, Emily C. Scribe, PharmD, Sai Prasad N. Iyer, PhD, Kevin K. Chung, MD

Publikováno v: Critical Care Explorations, Vol 5, Iss 10, p e0995 (2023)

OBJECTIVES:. Acute kidney injury (AKI) requiring continuous kidney replacement therapy is a significant complication in ICU patients with mortality rates exceeding 50%. A dysregulated immune response can lead to systemic inflammation caused by hypera

Externí odkaz: https://doaj.org/article/ae437b8cebe34d67a9023f8e7b1ab77e

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání